Bulgaria vs Sweden: The number of people with susceptibility test result for rifampicin
Bulgaria
156
in 2021
Sweden
173
in 2021
Bulgaria rank
100th
Sweden rank
97th
The number of people with susceptibility test result for rifampicin over time
- Bulgaria
- Sweden
How they compare
Sweden currently reports 173 against 156 in Bulgaria, a difference of 17.
That makes Sweden's figure about 1.1 times Bulgaria's.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Bulgaria ahead.
Bulgaria ranks 100th and Sweden ranks 97th of 155 countries.
Bulgaria has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Bulgaria | Sweden | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 467.67 | 255 | 212.67 | Bulgaria |
| 2020s | 181.5 | 171 | 10.5 | Bulgaria |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Bulgaria or Sweden?
- Sweden, at 173 against 156 in Bulgaria as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Bulgaria and Sweden?
- 17, with Sweden ahead.
- How many years of comparable data are there for Bulgaria and Sweden?
- 5 years are reported by both, from 2017 to 2021.
- How do Bulgaria and Sweden rank globally for the number of people with susceptibility test result for rifampicin?
- Bulgaria ranks 100th and Sweden ranks 97th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.